Decoding the Cardiac Immune Microenvironment and Fibroblast Crosstalk in Radiotherapy Combined with Immunotherapy‐Induced Cardiac Fibrosis Based on Single‐Cell Transcriptomic Analysis
Advanced Science · 2026-05 · 13 (25)
DOI: 10.1002/advs.202519216 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, online erschienen am 20.02.2026. Verfasst von Yuxi Luo und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi Province, China. Hauptthemen laut MEDLINE: Fibroblasts, Fibrosis, Immunotherapy, Radioimmunotherapy. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Jiangxi Province, National Natural Science Foundation Incubation Program of the Second Affiliated Hospital of Nanchang University.
Abstract (Originalsprache)
Purpose
The combination of radiotherapy and immunotherapy (radioimmunotherapy) shows promising antitumor efficacy but raises cardiotoxicity concerns. The underlying mechanisms remain unclear.
Methods
Preclinical models were used to assess cardiac function at day 28, 3 months, and 5 months post radioimmunotherapy intervention. The scRNA‐seq and molecular experiments were conducted. IL‐6 knockout mice and tocilizumab (IL‐6R inhibitor) were used for targeted interventions.
Results
Radioimmunotherapy exacerbated cardiac fibrosis and enhanced fibroblast‐immune cell crosstalk, accompanied by robust activation of IL‐6 signaling predominantly derived from fibroblasts. Elevated serum IL‐6 levels were also observed in patients receiving combined thoracic radiotherapy and immunotherapy. Both IL‐6 knockout and tocilizumab treatment effectively alleviated acute cardiac injury, inflammation, and fibrosis. Notably, tocilizumab likely inhibits the IL‐6 + fibroblasts‐mediated activation of themselves and CCR2 + macrophages, which these subsets exhibit enhanced pro‐fibrotic scores in radioimmunotherapy‐induced cardiac damage. Moreover, alterations in immune checkpoint molecules were observed in the cardiac microenvironment following radioimmunotherapy. Macrophages with high IL‐6 signaling activity exhibited elevated CD86 expression, which was reduced upon tocilizumab treatment.
Conclusions
Our study identifies fibroblast‐immune cell interactions, particularly IL‐6‐mediated fibroblast‐macrophage crosstalk, as a key mechanism in radioimmunotherapy‐induced cardiac fibrosis. Tocilizumab, an IL‐6R inhibitor, demonstrates therapeutic potential to attenuate this cardiotoxicity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Oncology, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi Province, China.
- Jiangxi Province Key Laboratory of Precision Cell Therapy, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi Province, China.
- Radiation Induced Heart Damage Institute, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi Province, China.
- Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Nanchang University, Nanchang, Jiangxi Province, China.
ORCID-Profile: Anwen Liu
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Jiangxi Province
- National Natural Science Foundation Incubation Program of the Second Affiliated Hospital of Nanchang University
- Ganpo Talent Program-Innovative Leadership Talent Project
Zitieren
APA
Luo, Y., Yu, Y., Zeng, Z., Chen, Y., Yi, Y., Lu, Z., Zeng, F., Xu, P., Luo, D., Chen, L., & Liu, A. (2026). Decoding the Cardiac Immune Microenvironment and Fibroblast Crosstalk in Radiotherapy Combined with Immunotherapy‐Induced Cardiac Fibrosis Based on Single‐Cell Transcriptomic Analysis. Advanced Science, 13(25). https://doi.org/10.1002/advs.202519216
Vancouver
Luo Y, Yu Y, Zeng Z, Chen Y, Yi Y, Lu Z, et al. Decoding the Cardiac Immune Microenvironment and Fibroblast Crosstalk in Radiotherapy Combined with Immunotherapy‐Induced Cardiac Fibrosis Based on Single‐Cell Transcriptomic Analysis. Advanced Science. 2026;13(25). doi:10.1002/advs.202519216
BibTeX
@article{Luo2026,
author = {Luo, Yuxi and Yu, Ying and Zeng, Zhimin and Chen, Yanxin and Yi, Yali and Lu, Zhiqin and Zeng, Fujuan and Xu, Peng and Luo, Daya and Chen, Leifeng and Liu, Anwen},
title = {Decoding the Cardiac Immune Microenvironment and Fibroblast Crosstalk in Radiotherapy Combined with Immunotherapy‐Induced Cardiac Fibrosis Based on Single‐Cell Transcriptomic Analysis},
journal = {Advanced Science},
year = {2026},
volume = {13},
number = {25},
doi = {10.1002/advs.202519216}
}
EUVIMED